Anders Edsjö (Former)
11 – 20 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells.
(
- Contribution to journal › Article
- 2012
-
Mark
Do Pre-Analytical Parameters Explain KRAS Test Sensitivity Disparities? Reply
(
- Contribution to journal › Letter
-
Mark
Implementation of Formalin-Fixed, Paraffin-Embedded Cell Line Pellets as High-Quality Process Controls in Quality Assessment Programs for KRAS Mutation Analysis
(
- Contribution to journal › Article
- 2011
-
Mark
Elevated level of wnt5a protein in localized prostate cancer tissue is associated with better outcome.
(
- Contribution to journal › Article
-
Mark
Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells.
(
- Contribution to journal › Article
- 2010
-
Mark
miR-34c is down regulated in prostate cancer and exerts tumor suppressive functions.
(
- Contribution to journal › Article
-
Mark
Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
(
- Contribution to journal › Article
- 2009
-
Mark
DEVELOPMENT OF A MIRNA ASSAY FOR PROSTATE CANCER DETECTION
2009) 24th Annual Congress of the European Association of Urology In European Urology Supplements 8(4). p.316-316(
- Contribution to journal › Published meeting abstract
- 2007
-
Mark
Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation.
(
- Contribution to journal › Scientific review
- 2005
-
Mark
Multidrug-resistant neuroblastoma cells are responsive to arsenic trioxide at both normoxia and hypoxia.
(
- Contribution to journal › Article